Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor (Q39169737)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 April 2013
edit
Language Label Description Also known as
English
Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor
scientific article published on 5 April 2013

    Statements

    Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor (English)
    0 references
    0 references
    0 references
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit